Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Chime Financial, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Chime Financial, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001795586-26-000048
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Transaction and risk losses | 103,287 | 98,247 | 192,192 | 207,392 |
| Member support and operations | 109,555 | 203,097 | 204,954 | 281,706 |
| Sales and marketing | 164,159 | 185,006 | 329,590 | 317,579 |
| Technology and development | 112,111 | 621,754 | 221,891 | 699,636 |
| General and administrative | 80,142 | 279,667 | 150,609 | 326,840 |
| Depreciation and amortization | 4,297 | 3,896 | 8,465 | 7,703 |
| Total operating expenses | 573,551 | 1,391,667 | 1,107,701 | 1,840,856 |
| Income (loss) from operations | 21,322 | (930,638) | 67,485 | (921,501) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Chime Financial, Inc.'s R&D?
- Chime Financial, Inc. (CHYM) reported R&D of $112.11M in Q2 2026.
- How has Chime Financial, Inc.'s R&D changed year-over-year?
- Chime Financial, Inc.'s R&D decreased by 82.0% year-over-year, from $621.75M to $112.11M.
- What is the long-term trend for Chime Financial, Inc.'s R&D?
- Over 2 years (2023 to 2025), Chime Financial, Inc.'s R&D has grown at a 90.0% compound annual growth rate (CAGR), from $259M to $934.93M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Chime Financial, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude